Samsung Biologics Co Ltd
207940.KS · Health Technology · Medical Specialties · KR
About
Samsung Biologics Co Ltd is a biotechnology company based in South Korea. The company was founded in 2011 by Samsung Group and has since become one of the world's leading providers of biopharmaceutical manufacturing services. Samsung Biologics aims to improve the conduct of clinical studies by providing top-quality biopharmaceutical products and services. The business model of Samsung Biologics is to manufacture biopharmaceuticals for internationally leading pharmaceutical and biotechnology companies. The company offers a wide range of services, including cell line development, process development, and production processes.
Annual results
Reported figures, KRW · revenue up 30.3% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 4.6T | 1.8T | 39.2% | — |
| 2024 | 3.5T | 1.1T | 31.0% | — |
| 2023 | 3.7T | 858B | 23.2% | — |
| 2022 | 3.0T | 798B | 26.6% | — |
| 2021 | 1.6T | 394B | 25.1% | — |
207940.KS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Samsung Biologics Co Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.